Beyaz Approval History
- FDA approved: Yes (First approved September 24th, 2010)
- Brand name: Beyaz
- Generic name: drospirenone, ethinyl estradiol and levomefolate calcium
- Company: Bayer HealthCare Pharmaceuticals Inc.
- Treatment for: Birth Control, Premenstrual Dysphoric Disorder, Acne
Beyaz (drospirenone, ethinyl estradiol and levomefolate calcium) is an estrogen/progestin combined oral contraceptive containing a folate, indicated for use by women to prevent pregnancy, treat symptoms of premenstrual dysphoric disorder, treat moderate acne and to raise folate levels in women who choose to use an oral contraceptive for contraception.
Development History and FDA Approval Process for Beyaz
|Sep 27, 2010||FDA Approves Beyaz - Combination Contraceptive Containing a Folate|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.